919PPROS AND CONS OF ADDING OF NEOADJUVANT CHEMOTHERAPY TO STANDARD CONCURRENT CHEMORADIOTHERAPY IN CERVICAL CANCER: A REGIONAL CANCER CENTER EXPERIENCE.